Sana Biotechnology, Inc.·4

Apr 11, 4:26 PM ET

WILLIAMS DOUGLAS E 4

4 · Sana Biotechnology, Inc. · Filed Apr 11, 2023

Insider Transaction Report

Form 4
Period: 2023-04-10
WILLIAMS DOUGLAS E
EVP & President, R&D
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-04-10+1,100,0001,100,000 total
    Exercise: $3.28Exp: 2033-04-09Common Stock (1,100,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying shares on April 10, 2024 and in 36 equal monthly installments thereafter.

Documents

2 files
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY